Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | ACH Accendra Health, Inc. | ABBV AbbVie |
|---|---|---|
| Price | $1.12 +3.7% | $261.77 +1.8% |
| StockIQ Score | 39F Weak Risk: High | 53C- Moderate Risk: Medium |
| Technical | 28F | 61C+ |
| Fundamental | 42D | 56C |
| Growth | 34F | 34F |
| Fair Value | 50C- | 33F |
| News | 50C- | 92A+ |
| Quality | 47D+ | 47D+ |
| Risk | 32F | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Accendra Health (ACH) and AbbVie (ABBV) differ in key areas. AbbVie shows stronger investor confidence with a higher investor score (52 vs. 42) and a moderate rating, while ACH is rated weak. AbbVie also leads in technical (58 vs. 38) and fundamental (56 vs. 42) scores, though both share the same growth score of 34. ACH has a better valuation score (50 vs. 33), indicating it may be priced more favorably.